226 related articles for article (PubMed ID: 8810894)
1. Prescription drug diversion.
Va Med Q; 1996; 123(2):132. PubMed ID: 8810894
[No Abstract] [Full Text] [Related]
2. PADS approach to preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
[No Abstract] [Full Text] [Related]
3. Prescription drug diversion: "what Lola wants, Lola gets".
Thomison JB
J Tenn Med Assoc; 1989 Jan; 82(1):35-7. PubMed ID: 2927111
[No Abstract] [Full Text] [Related]
4. The Illinois experience in achieving the medical/regulatory balance required to control prescription drug diversion.
Bishop MT; Vlasty RJ
NIDA Res Monogr; 1993; 131():159-75. PubMed ID: 8413527
[No Abstract] [Full Text] [Related]
5. An American Medical Association perspective on preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
[No Abstract] [Full Text] [Related]
6. The dentist and prescription drug abuse.
Balevi B; Breen L; Krasnowski J
J Can Dent Assoc; 1996 Jan; 62(1):56-60. PubMed ID: 8673939
[TBL] [Abstract][Full Text] [Related]
7. New prescription drug abuse laws.
Howe CW
Mich Med; 1988 Aug; 87(8):463, 508. PubMed ID: 3193903
[No Abstract] [Full Text] [Related]
8. Controlled substances bill biggest healthcare issue of session.
W V Med J; 2012; 108(3):102. PubMed ID: 22792665
[No Abstract] [Full Text] [Related]
9. The Medicaid Prescription Drug Initiative.
Roslewicz TD
NIDA Res Monogr; 1993; 131():200-5. PubMed ID: 8413531
[No Abstract] [Full Text] [Related]
10. New York State's Triplicate Prescription Program.
Eadie JL
NIDA Res Monogr; 1993; 131():176-93. PubMed ID: 8413528
[No Abstract] [Full Text] [Related]
11. Prescription drug use and abuse.
Meadows M
FDA Consum; 2001; 35(5):18-24. PubMed ID: 11697087
[No Abstract] [Full Text] [Related]
12. PADS: a program to identify and diagnose prescription drug diversion in Indiana.
Indiana Med; 1987 Sep; 80(9):874-6. PubMed ID: 3668236
[No Abstract] [Full Text] [Related]
13. Va. doctors to report controlled substances. Program targets drugs with high potential for abuse, e.g., oxycontin, percocet.
Lubell J
Mod Healthc; 2006 Jun; 36(26):32. PubMed ID: 16841650
[No Abstract] [Full Text] [Related]
14. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
Joranson DE
NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
[No Abstract] [Full Text] [Related]
15. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA.
Fishman SM
Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882
[No Abstract] [Full Text] [Related]
16. Physician perspectives on a pilot prescription monitoring program.
Barrett K; Watson A
J Pain Palliat Care Pharmacother; 2005; 19(3):5-13. PubMed ID: 16219606
[TBL] [Abstract][Full Text] [Related]
17. Summary and conclusions of a review of prescription drug diversion control methods.
Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
[No Abstract] [Full Text] [Related]
18. There ought to be a law.
Gordon JB
West J Med; 1990 Sep; 153(3):331. PubMed ID: 2219908
[No Abstract] [Full Text] [Related]
19. Commentary in response to Paulozzi et al.: prescription drug abuse and safe pain management.
Fishman SM
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):628-31. PubMed ID: 16862601
[No Abstract] [Full Text] [Related]
20. Prescription data processing--its role in the control of drug abuse.
Maronde RF; Seibert S; Katzoff J; Silverman M
Calif Med; 1972 Sep; 117(3):22-8. PubMed ID: 5070695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
